Ultrasound imaging is an important tool in the diagnosis of fetal anomalies. It is a non-invasive, safe and cost-effective method of obtaining information about the baby before birth. An ultrasound can detect a variety of fetal abnormalities, including anencephaly, a rare neural tube defect. Anencephaly is a serious birth defect in which the baby is born without parts of the skull and brain. This article will discuss the ultrasound features of anencephaly and the implications for prenatal diagnosis.
Anencephaly is a birth defect that occurs in the early stages of pregnancy. It is a type of neural tube defect (NTD) in which the baby is born without parts of the skull and brain. It is a serious condition and is usually fatal. Most babies with anencephaly die shortly after birth. The cause of anencephaly is not known. It is thought to be due to a combination of genetic and environmental factors.
Ultrasound is the primary imaging modality used to diagnose anencephaly. It is a safe and cost-effective method of obtaining information about the baby before birth. An ultrasound can detect a variety of fetal abnormalities, including anencephaly. The ultrasound features of anencephaly include:
The diagnosis of anencephaly is usually made in the second trimester of pregnancy, usually between 18 and 20 weeks. It is important to note that anencephaly can be misdiagnosed or missed on ultrasound. It is important to have an experienced sonographer and radiologist to accurately diagnose anencephaly.
The diagnosis of anencephaly can be devastating for parents. It is important to provide accurate information and counseling to the parents. The diagnosis of anencephaly can be difficult for the parents to accept and understand. It is important to provide support and resources to the parents to help them cope with the diagnosis. The diagnosis of anencephaly can also have implications for the management of the pregnancy. It is important to discuss the options with the parents, including the option of pregnancy termination. It is important to provide accurate information and to explain the risks and benefits of each option.
Ultrasound imaging is an important tool in the diagnosis of fetal anomalies. An ultrasound can detect a variety of fetal abnormalities, including anencephaly. Anencephaly is a serious birth defect in which the baby is born without parts of the skull and brain. The ultrasound features of anencephaly include a lack of skull bones, absence of the cerebrum and cerebellum, enlargement of the lateral ventricles, underdeveloped brain stem, enlarged cisterna magna, increased amount of amniotic fluid, and enlarged head circumference. The diagnosis of anencephaly can be devastating for parents and can have implications for the management of the pregnancy. It is important to provide accurate information and counseling to the parents and to discuss the options with them.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation